Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Neurology/Psychiatric

Grünenthal and King’s College London collaborate on iPSC-based microfluidic culture models for pain research

April 27, 2023

Grünenthal Gmbh and King’s College London have entered into a 24-month collaboration to develop microfluidic culture (MFC) models based on human induced pluripotent stem cells (iPSCs) for pain research.

Cross section illustration of ion channel in cell membrane

Drug Design, Drug Delivery & Technologies

Veneno enters joint research agreement with Sumitomo Pharma targeting ion channels

April 19, 2023

Veneno Technologies Co. Ltd. has entered into a joint research agreement with Sumitomo Pharma Co. Ltd. under which Veneno will conduct a program to obtain functional peptides (disulfide-rich peptides) for ion channels targeted by Sumitomo Pharma.

Immuno-oncology

Neophore signs research collaboration agreement with ICR to explore use of MMR modulators

April 19, 2023

Neophore Ltd. has signed a strategic research...

Immune

Daewoong Pharmaceutical collaborates with Sygnature Discovery on autoimmune disease drug discovery

April 19, 2023

Daewoong Pharmaceutical Co. Ltd. has entered...

Cancer

WARF and Ginkgo Bioworks partner to discover next-generation GD2 CAR T-cell therapies

April 14, 2023

The Wisconsin Alumni Research Foundation (WARF) and Ginkgo Bioworks Inc. have announced a partnership to leverage Ginkgo's proprietary high-throughput combinatorial chimeric antigen receptor (CAR) discovery and screening platform with the aim of discovering next-generation GD2 CAR T-cell therapies.

Immuno-oncology

Pyramid Biosciences and Genequantum Healthcare enter license agreement for ADC targeting TROP2

April 14, 2023

Pyramid Biosciences Inc. and Genequantum Healthcare (Suzhou) Co. Ltd. have entered into an exclusive license agreement to develop and commercialize GQ-1010, a potential best-in-class antibody-drug conjugate (ADC) targeting trophoblast cell surface antigen 2 (TROP2), worldwide except for Greater China (mainland China, Hong Kong, Macau, and Taiwan).

Cancer

Biotheryx and Incyte collaborate on targeted protein degraders for novel oncology targets

April 6, 2023

Biotheryx Inc. has entered into a research collaboration and license agreement with Incyte Corp. to discover and develop targeted protein degraders for novel oncology targets.

Neurology/Psychiatric

Respirerx collaborates with UCL to study Ampakines for GRIA disorders

April 6, 2023

Respirerx Pharmaceuticals Inc. has entered into...

Cancer

Absci and M2gen partner on cancer drug discovery

April 5, 2023

Absci Corp. and M2gen have entered into a partnership to create new cancer medicines. Absci’s generative artificial intelligence drug creation platform will leverage M2gen’s clinical and molecular data set, ORIEN Avatar, to accelerate the creation of therapeutics for a range of malignancies and patient profiles.

Neurology/Psychiatric

Calyx and Ceretype Neuromedicine partner to advance psychiatric treatment development

April 5, 2023

Calyx (Perceptive Informatics LLC) has entered into a strategic partnership with Ceretype Neuromedicine Inc., whose novel functional magnetic resonance imaging (fMRI) platform incorporates optimal image acquisition and advanced analytics to de-risk and accelerate the development of psychiatric and neurological therapies

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...

Collaboration RSS

Collaboration
RSS